The company said 571,000 people were screened for colon cancer with its noninvasive Cologuard test in 2017.
With new sequences from ancient Botai and Eurasian horses, researchers pinned early domestication to an area north of Kazakhstan.
The patent claims strategies for identifying optimal breeding combinations of crop plants or cattle within a breeding population.
Excluding the sale of the company's colorectal cancer patents to Exact Sciences, its 2017 revenues rose 13 percent.
The increased revenues were due primarily to cardiac immunoassay sales from the newly acquired Triage and BNP businesses as well as increased sales of rapid immunoassay products.
Using genomic data for hundreds of ancient Europeans, research teams retraced the spread of the Beaker complex culture as well as interactions between pastoralists and hunter-gatherers.
The company intends to use the funds to advance its Cota Nodal Address disease classification system and other platforms.
With the accreditation, the La Jolla, California-based molecular dermatology firm can provide its services in all 50 states and the District of Columbia.
The company said that an increase in clinical genetic testing volume contributed to overall revenue growth.
The PAXgene Blood ccfDNA tube enables clinical laboratories to stabilize samples when they cannot be processed on the day they were collected.
At the HL7 Genomics Conference, a FHIR Genomics developer unveiled the Consortium for Agile Genomics to promote implementation of the nascent standard.
Sequencing of typhoid fever outbreak samples in Pakistan indicates extensive drug resistance arose when a local multidrug resistance strain acquired a new plasmid.
The updated recommendations discuss testing for DNA repair gene mutations, MSI-H, and dMMR, as well as germline testing and counseling.
Nohla will use Karius' NGS plasma test for pathogen detection in a randomized trial evaluating Nohla's lead product, a cellular therapy called NLA101.
Researchers sequenced the genome of an ancient Caribbean woman to find present-day individuals are descendants of the indigenous Taino.
Last week, GenomeWeb's readers were most interested in Roche's acquisition of oncology-focused electronic health records maker Flatiron Health for $1.9 billion.
GenomeNext's Olympus platform now includes search results from Genomenon's Mastermind analytic and data visualization tool.
Under the agreement, the researchers plan to sequence 150 AML genomes and transcriptomes to look for population-specific variants.
Investigators identified mutation, expression, and methylation differences in colorectal polyps from individuals with or without colorectal cancer.
The bill aims to reduce barriers to the use of genetic and genomic testing, including for children on Medicaid with a suspected genetic disease.
London-based LGC said that the acquisition increases its exposure to the next-generation sequencing and gene editing markets.
The test is based on the company's GARD platform for measuring genetic biomarkers of immune reactions to predict chemical sensitivities.
In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.
The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.
Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.
In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.